Acute hepatitis after a loading dose of intravenous amiodarone.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E Aliot.
Explore the source record for details and available documents.
Adequate processing of left ventricular angiograms depends on the visualisation of all segments of the ventricular wall. At the same time, subtraction of different images can enhance different heart segments but commercially available methods do not allow simultaneous viewing of several images masked by different processes. Using our software, for each studied frame, a four quadrant display permits the simultaneous visualisation of a mask mode image, a diastolic-systolic difference image, an image obtained by subtraction of a frame at the same cycle time and a composite mask subtracted image. The composite mask image is obtained by weighting three images according to videodensitometric measurements by reference to previously acquired data. This method facilitates contour delineation and computation of the ejection fraction by area-length method. Correlation with radionuclide estimates of left ventricular ejection fraction is higher (n = 60, r = 0.90, SEE = 8%) than using the classical mask mode display (n = 60, r = 0.82, SEE = 11%). In a subgroup of 30 patients the contrast medium was injected in an antecubital vein and the correlation coefficient remained satisfactory (n = 30, r = 0.89, SEE = 7%) when compared with the classical subtraction technique (n = 30, r = 0.70, SEE = 12%). We therefore conclude that the composite mask method gives comparatively similar values for left ventricular ejection fraction to those acquired by radionuclide angiography.
Sixty patients with recurrent inducible sustained ventricular tachycardia were prospectively treated with nadolol (40 or 80 mg/day). Old myocardial infarction was present in 43 patients and dilated cardiomyopathy in 12. In group I (n = 36), nadolol was given alone, whereas in group II (n = 24), previously ineffective treatment with amiodarone was continued in combination with nadolol. Left ventricular ejection fraction was higher in patients in group I (0.40 +/- 0.12) than in group II (0.30 +/- 0.10, p less than 0.01) patients. Electrophysiologic study was repeated after short-term treatment with nadolol, which was continued regardless of the results of this test, according to the scheme of the parallel approach. Recurrence of spontaneous tachycardia or sudden death occurred in 21 patients after 10 +/- 9.2 months; sustained tachycardia was inducible in 19 on nadolol therapy. The remaining 39 patients (of whom 21 had inducible tachycardia while taking the drug) have had no recurrence of tachycardia after 27.8 +/- 9.3 months of follow-up study. Sensitivity, specificity and predictive value of a positive and negative test were 90.5%, 46%, 47.5% and 90%, respectively. The results differ between group I and group II patients, the latter having a high percent of false positive responses. This difference is even more obvious with respect to left ventricular ejection fraction: the predictive value of a positive test was 86% when ejection fraction was greater than 0.40 and 39% when it was less than 0.40.(ABSTRACT TRUNCATED AT 250 WORDS)
In spite of the frequency of unstable angina, the number of clinical trials which permit to evaluate the value of conventional medical treatments, remains limited, especially because of the difficulties in finding a "specific tracer" of the efficacy of the standard drugs used. The common form of unstable angina is different from the spastic form, in that inducement tests permit, in Prinzmetal angina, better codified selection and monitoring of the patients. The literature is reviewed for each therapeutic family (calcium inhibitors, amiodarone, nitro-compounds, molsidomine, etc.). On a short term basis, the conventional treatment permits, most of the time to perform a coronary angiography under good conditions. On a long term basis, medical treatment and surgical procedure give similar results, except for patients with three-vessels disease in whom surgical revascularization provides a more comfortable life.
Explore the source record for details and available documents.
The effects of isoprenaline on the induction of supraventricular tachycardia by programmed stimulation were studied in 67 patients to see whether they correlated with spontaneous catecholamine mediated symptoms during exercise testing and Holter monitoring. Thirty seven control patients (group 1) did not have spontaneous arrhythmias either during exercise testing or Holter monitoring. Thirty patients (group 2) had documented exercise or stress related supraventricular tachycardias--that is paroxysmal junctional tachycardia (24) or atrial arrhythmia (6). Programmed electrical stimulation was performed before and during the infusion of isoprenaline. No group 1 patient developed sustained supraventricular tachycardia during isoprenaline infusion. In 21 patients with paroxysmal junctional tachycardia and all the patients with atrial arrhythmias electrical stimulation during isoprenaline infusion produced the same tachycardia that had been seen during exercise testing and Holter monitoring. Changes in electrophysiological variables and the concentrations of serum potassium were not associated with the induction of supraventricular tachycardia by isoprenaline. Infusion of isoprenaline safely facilitated the induction of supraventricular tachycardia by programmed stimulation in patients who had spontaneously occurring catecholamine mediated symptoms.
The hemodynamic and electrophysiologic effects of rilmenidine were examined after single oral administration to hypertensive patients. In 8 untreated hypertensive patients, cardiac output, pulmonary pressure and blood pressure were measured before and for 10 hours after the administration of 25 micrograms/kg of rilmenidine (1.3 to 2.4 mg, mean 1.88). In addition, electrophysiologic investigations were performed before and 2 hours after administration. Hemodynamics were repeated in 8 other hypertensive patients receiving 50 micrograms/kg rilmenidine (3.0 to 4.8 mg, mean 3.85 mg). The electrophysiologic study was repeated in 8 other hypertensive patients receiving 50 micrograms/kg of rilmenidine (3.2 to 4.4 mg, mean 3.90). In contrast to the results obtained at the dose of 50 micrograms/kg, there was no significant variation in pulmonary arterial pressure, cardiac index or stroke index after administration of 25 micrograms/kg. No significant variation was observed in heart rate, sinus function, conduction parameters or atrial, nodal and ventricular refractory periods after administration of 25 and 50 micrograms/kg. Rilmenidine, after single oral administration at the 25 micrograms/kg dose, led to a significant reduction in blood pressure and peripheral resistance without any significant change in cardiac output; the 25- and 50-micrograms/kg doses led to no alteration in heart rate and cardiac electrophysiology.
Explore the source record for details and available documents.
Nowadays, anaesthetists often have to deal with pacemaker patients. All the problems encountered in the anaesthetic management of such patients are discussed in this paper: the pacemaker, specific risks linked to the pacemaker, monitoring of such patients, and temporary pacing. The preoperative assessment of pacemaker function is an absolute necessity. The technical characteristics of the pacemaker can be found in the patient's booklet. The clinical history should reveal a possible malfunction (syncopes). The underlying cardiac disease should be known, as it will have repercussions on the anaesthetic and surgical risks. An electrocardiogram and measurement of blood electrolytes must be carried out. There are three major risks linked to the pacemaker during surgery: 1) the loss of pacing by threshold (drugs, dyskaliemia); threshold (drugs, dyskalemia); 2) ventricular fibrillation (the intracardiac electrode conducting the electrocautery currents); 3) reprogramming or damaging of the pacemaker by electrocautery, cardioversion or nuclear magnetic resonance. The only mandatory monitoring of these patients is the electrocardioscope. Other monitoring techniques will be dictated by the underlying cardiac disease or the surgery planned. Temporary pacing is indicated in the same conditions as permanent pacing. However the intracardiac electrode can be displaced by moving the patient; the efficacy of pacing must therefore be continuously checked. During cardiac surgery, with cardiopulmonary bypass, conduction disturbances can occur. Temporary pacing electrodes should therefore be sewn onto the ventricular epicardium for the duration of the surgery; atrial electrodes should be added if sinus troubles can be expected. Oesophageal pacing is possible in the operating theatre because it is easily and rapidly set up: a bipolar oesophageal electrode linked to an external pacer can speed up the heart (atrial dysfunction) or slow down a tachycardia. An oesophageal electrocardiogram can also be carried out with this electrode. Swan-Ganz catheters can be also used for temporary pacing: either with two pairs of electrodes, atrial and ventricular respectively--this system being useful in a patient who does not move--or with a newer system where a single small electrode is introduced into the right ventricle by a special lumen in the Swan-Ganz catheter. Although external pacing was historically the first technique to be developed, it was abandoned because of the muscle pains it gave. Recently, a new technique of external pacing, with large electrodes and longer stimuli, has been developed for use in emergency situations.(ABSTRACT TRUNCATED AT 400 WORDS)
Complete data concerning long-term results of transcatheter electrical ablation of the atrioventricular junction is not available. At the request of the French Cardiac Arrhythmia Working group we undertook an inquiry in October 1983. All centers potentially able to perform such procedures were asked to report their experience. Eight centers have performed one case or more, over a period of 3 years, for a total of 91 patients. The mean follow-up completed in all patients in April 1986 was 12 +/- 10 months. The procedure was indicated for a supraventricular arrhythmia resistant to a mean of 3.9 +/- 1.3 classes of antiarrhythmic agents. Atrial flutter or fibrillation in 54 (59%) and atrioventricular nodal reentry in 17 (18%) were the most common arrhythmias. A mean of 2.6 +/- 2.3 electrical shocks (range 1-14 shocks) with a stored energy of 130-400 joules was delivered during 1-5 sessions. Complete heart block was obtained in 83 patients and persisted at the time of discharge from the hospital in 46 patients (50.5%). The immediate complication (within 24 hours after the procedure) included ventricular fibrillation successfully converted (one patient) and nonsustained ventricular tachycardia (three patients). Late complications included one death 3 days after the procedure, in a patient in whom sustained ventricular tachycardia was documented, nonsustained ventricular tachycardia in two patients, sepsis in three patients and pericardial effusion in one patient. At the time of the follow-up, there were three additional deaths related to sepsis due to pacemaker pocket infection in one patient and to preexisting congestive heart failure in two patients.(ABSTRACT TRUNCATED AT 250 WORDS)
The 10 year outcome of patients with single vessel coronary artery disease who underwent coronary angiography more than 10 years before and who would have been potential candidates for percutaneous transluminal coronary angioplasty had it been available then is reported. Long term follow up data were obtained in 96 (91 men, five women; mean age 48 years) of 105 consecutive patients with single vessel coronary artery disease (greater than 70% stenosis), judged suitable for coronary angioplasty. Fifty patients had coronary bypass surgery within six months of catheterisation (surgical group) and 46 were treated medically (medical group). At entry to the study more patients in the surgical group had unstable angina, but fewer had a previous history of myocardial infarction. Ten year survival was 91% and remained excellent in all the subsets analysed. Moreover, the quality of life of these patients was good. Over the 10 year follow up, 16 (36%) of the patients treated medically and 13 (26%) in the surgical group were admitted to hospital because of cardiovascular events (including late coronary surgery in four of the patients treated medically). Lastly, 54/69 (78%) of the patients who were employed before catheterisation resumed work and 29 (42%) were still employed 10 years later. Although these data must be interpreted with care because of the limitations inherent in all retrospective studies, it appears that the long term results of conventional medical or surgical treatment are excellent in patients with single vessel coronary artery disease in whom percutaneous transluminal coronary angioplasty is now an option.
The authors advocate a semiquantitative evaluation of mitral regurgitation (MR), based on the extent of the left intra-atrial systolic jet. Their study was performed in a series of 63 consecutive patients explored by: (1) catheterization with left ventriculography on two planes for either ischaemic heart disease (24 cases) or cardiac valve disease (39 cases including 2 with mitral valve prosthesis), and (2) pulsed Doppler ultrasound combined with two-dimensional echocardiography for evaluation of MR carried out 24 or 48 hours prior to catheterization. Five grades of MR (0 to IV) were determined by ventriculography according to the time and degree of left atrial opacification. Similarly, five grades of MR (0 to IV) were determined by Doppler ultrasound, considering only the maximum distance from the mitral annulus plane. This distance was evaluated on at least 3 projections: apical for the 4 and 2 cavities, parasternal for the greater axis. The Doppler method correlated fairly well with the angiography, whether or not grade 0 was included (r = 0.87 and r = 0.72 respectively). However, some major MR may be underestimated; thus, out of 13 RM of angiographic grade III or IV, three (23 p. 100) were graded II by the Doppler technique. Conversely, some minute or moderate MR may be overestimated: out of 33 MR of angiographic grade I or II, four (12 p. 100) were graded III or IV by the Doppler technique.(ABSTRACT TRUNCATED AT 250 WORDS)
Programmed ventricular stimulation (PVS) has been advocated as being capable of identifying patients with idiopathic non obstructive dilated cardiomyopathy (NOCM) and at high risk of sudden death. We have studied the results of that method in 56 patients aged from 29 to 69 years (mean 53 years) presenting with idiopathic NOCM. The patients were divided into two groups according to the presence or absence of ventricular tachycardia (VT). Group I (controls) comprised 23 patients without documented VT. Group II consisted of 33 patients with documented VT which was sustained in 5 cases. Finally, 7 patients from both groups experienced losses of consciousness. Ventricular stimulation was performed on 2 sites of the right ventricle, using 1 to 3 extrastimuli on 2 imposed cycles. It was repeated under isoprenaline on 25 occasions. PVS induced non sustained ventricular tachycardia (NSVT) in only 2 patients of group I; it reproduced the sustained ventricular tachycardia (SVT) observed in the 5 patients with spontaneous SVT. PVS was negative in 14 of the 28 patients with NSVT; it induced NSVT in 8/28 and SVT in 6/28 (including 4 with more than 280 beats/min). The isoprenaline test failed to induce SVT. 7 patients died suddenly: 3 presented with SVT and 4 had syncopes and NSVT; ventricular stimulation induced SVT in 3 of these 4 patients. It is concluded that induction of sustained VT is uncommon in NOCM, but a history of syncope should prompt a search for SVT. Patients with spontaneous symptomatic NSVT and inducible SVT must be considered at high risk of sudden death.
Penticainide is a new class I antiarrhythmic agent. Its electrophysiological effects and pharmacokinetic properties were studied in 28 patients undergoing endocavitary exploration for paroxysmal supraventricular tachycardia (10 cases), WPW syndrome involving an accessory pathway (5 cases), and unexplained dizziness (13 cases). Increasing doses of penticainide were infused in the first 18 patients (0.12 up to 3.5 mg kg-1). The next ten patients received 4 mg kg-1 over a 30 minute period. Penticainide shortened the sinus cycle length and increased the transnodal conduction time. The ventricular conduction time tended to increase. Atrial functional refractory period increased when atrioventricular nodal and ventricular refractory periods remained unchanged. In patients with previous supraventricular tachycardias all triggered arrhythmias were prevented with dosages higher than 2 mg kg-1 and related blood levels higher than 3 mg l-1. A dose-dependency of plasma and renal clearance was documented. Average Cmax values after 4 mg kg-1 was 7.37 +/- 1.28 mg l-1. No adverse events occurred during the trial and penticainide proved to be well tolerated.
Between 1974 and 1984, 207 patients with Wolff-Parkinson-White syndrome (WPW) were admitted to our hospital department; 195 of them were followed up for periods ranging from 1 to 12 years (6 years in children, 3 years and 9 months in adults on average); 160 had undergone electrophysiological exploration. Fifty-seven patients were less than 16 years old: 7 died, including 6 with associated congenital heart disease; an asymptomatic 12-year old girl died suddenly while taking part in a sporting event. The signs of WPW disappeared in 5 out of 10 children under 1 year of age. One hundred and thirty-eight patients were older than 15: 15 of them died, but only 3 deaths were related to WPW: one was consecutive to surgery for WPW and one to fulguration; the third patient died of WPW tachyarrhythmia; the refractory period of his Kent's bundle was short, but his compliance with treatment was irregular. We found no correlation between changes in functional symptoms and Kent's bundle refractory period values; paradoxically, the frequency of attacks and resistance to treatment was higher in cases with long refractory period. On the whole, this series confirms that WPW usually is a benign disease. However, the risk of sudden death, of which it offers an example, indicates that all patients with WPW should be evaluated with at least an exercise test and, depending on its results or on the socio-professional context, an electrophysiological exploration.
The electrophysiological properties of carocainide a new Class I antiarrhythmic agent (Delalande Research Centre) were studied after intravenous injection of 3.5 mg/kg in 5 minutes in 16 patients aged 24 to 66 years. Five minutes after the injection there was a significant increase (p less than 0.01) in the HV (+/- 12.8 +/- 10.5 msec), AH (+ 21.8 +/- 14 msec) and PR intervals (+ 43.8 +/- 24.2 msec) and in the duration of QRS (+ 20.6 +/- 9.9 msec). The anterograde and retrograde Wenckebach points were decreased (-42 +/- 43 bpm and - 52 +/- 36 bpm respectively, p less than 0.05). All these effects reverted progressively 20 minutes after injection and disappeared by the 40th minute, which corresponds to the pharmaco-kinetic profile of the patient. There were no changes in blood pressure, sinus node function or refractory periods except for the retrograde refractory periods which were prolonged (+ 87 +/- 41 msec). Atrial fibrillation was induced in 2 patients and atrial flutter in 2 others by the extrastimulus technique. These arrhythmias could not be reproduced in these 4 patients during the 40 minutes after injection of carocainide. Five other patients with reciprocating nodal tachycardia induced by atrial extrastimuli had their arrhythmia interrupted by the carocainide injection. We conclude that carocainide acts mainly on atrio-ventricular and intra-ventricular conduction. The results obtained in patients with tachycardias suggest that the product is effective in atrial arrhythmias and paroxysmal junctional tachycardia.
Exercise tests involving isotopes were evaluated in 38 subjects presenting inferior myocardial necrosis. Cardiographic data were used to calculate sensitivity and specificity of the method in detection of subjects requiring surgical treatment. Sensitivity was 90% and specificity 62% when three criteria were employed: ECG of positive exertion, reversible diminished accumulation of thallium 201 outside the necrotic site or decrease in the fraction of ejection force. Examination of the fraction of ejection force improved the results of myocardial scanning using thallium and increased detection of subjects requiring surgery from 61% to 90%.
This study compared the phase images of 12 normal subjects and 14 patients with right ventricular and 5 patients with left ventricular preexcitation. The phase images obtained from equilibrium radionuclide ventriculographies in the left anterior oblique portion with an ECG trigger: Fourier analysis was used to measure the phase and amplitude of the variations. In normal subjects the mean difference in phase was nearly zero: in 12 of the 14 patients with right ventricular preexcitation, right ventricular preceded left ventricular contraction (LV phase - RV phase = + 23 degrees); injection of Ajmaline normalised the ECG and suppressed the premature right ventricular contraction during right ventricular preexcitation (LV phase - RV phase = nearly zero), demonstrating a direct relationship between the abnormal depolarisation and abnormal contraction. In left sided Kent bundles, phase imaging did not seem to show significant premature ventricular contraction under basal conditions. Atrial pacing, which accentuated both left and right electrical preexcitation, increased the difference in ventricular phase. Finally, a satisfactory correlation was observed between the presumed locations of the accessory pathways and the zones of premature right and left ventricular contraction.